The Drug Enforcement Administration has issued a final order that, effective Nov. 13, extends the temporary schedule I status for the following synthetic phenethylamines (including their optical, positional and geometric isomers, salts, and salts of isomers whenever the existence of such substances is possible) for one year or until the permanent scheduling action for these substances is completed, whichever occurs first.
• 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I-NBOMe; 2C-I-NBOMe; 25I; Cimbi-5)
ׇ• 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25C-NBOMe; 2C-C-NBOMe; 25C; Cimbi-82)
• 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25B-NBOMe; 2C-B-NBOMe; 25B; Cimbi-36)
The DEA states that as a result of this order, the full effect of the Controlled Substances Act and its implementing regulations, including criminal, civil and administrative penalties, sanctions and regulatory controls of schedule I substances, will continue to be imposed on the manufacture, distribution, possession, importation and exportation of these synthetic phenethylamines.
The DEA has concurrently issued a proposed rule that would permanently place these chemicals into schedule I of the CSA and is accepting comments on this proposal through Dec. 14.